Happy holidays

The strange year 2020 is coming to an end. It has been a challenging one for all of us. A year of digital meetings, a year without socializing at Lysebu or at workshops. Not the best conditions for networking. Nevertheless,… Read More ›

4th annual meeting 2020

Thank you all for your contribution to this year’s meeting! It was great to see that we had more participants this year than any previous year. We started out with a great talk by Renate Schnabel about Atrial fibrillation… Read More ›

NOACs differ with regard to bleeding risk

Non-vitamin K antagonist Oral Anticoagulants (NOACs) have become the mainstay therapy for stroke prophylaxis in atrial fibrillation. Although shown equally or more safe and effective than warfarin, there is limited knowledge of the comparative effectiveness and safety of the NOACs…. Read More ›